메뉴 건너뛰기




Volumn 93, Issue 1, 2005, Pages 75-83

Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer

Author keywords

Bone mineral density; Breast cancer; Chemotherapy; Hormonal treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; TAMOXIFEN;

EID: 25144455423     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-3803-0     Document Type: Article
Times cited : (20)

References (30)
  • 4
    • 0035879298 scopus 로고    scopus 로고
    • Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer
    • CL Shapiro J Manola M Leboff 2001 Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer J Clin Oncol 19 3306 3311
    • (2001) J Clin Oncol , vol.19 , pp. 3306-3311
    • Shapiro, C.L.1    Manola, J.2    Leboff, M.3
  • 5
    • 0038512527 scopus 로고    scopus 로고
    • The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer
    • NC Greep AE Giuliano NM Hansen T Taketani HJ Wang FR Singer 2003 The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer Am J Med 114 653 659
    • (2003) Am J Med , vol.114 , pp. 653-659
    • Greep, N.C.1    Giuliano, A.E.2    Hansen, N.M.3    Taketani, T.4    Wang, H.J.5    Singer, F.R.6
  • 6
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group
    • Early Breast Cancer Trialists' Collaborative Group 1998 Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 351 1451 1467
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 7
    • 0031045147 scopus 로고    scopus 로고
    • Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens
    • T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa 1997 Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens Br J Cancer 75 602 605
    • (1997) Br J Cancer , vol.75 , pp. 602-605
    • Saarto, T.1    Blomqvist, C.2    Valimaki, M.3    Makela, P.4    Sarna, S.5    Elomaa, I.6
  • 8
    • 0030070093 scopus 로고    scopus 로고
    • Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
    • TJ Powles T Hickish JA Kanis A Tidy S Ashley 1996 Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women J Clin Oncol 14 78 84
    • (1996) J Clin Oncol , vol.14 , pp. 78-84
    • Powles, T.J.1    Hickish, T.2    Kanis, J.A.3    Tidy, A.4    Ashley, S.5
  • 10
    • 0028033883 scopus 로고
    • Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years
    • RR Love HS Barden RB Mazess S Epstein RJ Chappell 1994 Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years Arch Intern Med 154 2585 2588
    • (1994) Arch Intern Med , vol.154 , pp. 2585-2588
    • Love, R.R.1    Barden, H.S.2    Mazess, R.B.3    Epstein, S.4    Chappell, R.J.5
  • 12
    • 0029559180 scopus 로고
    • The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women
    • AB Grey JP Stapleton MC Evans MA Tatnell RW Ames IR Reid 1995 The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women Am J Med 99 636 641
    • (1995) Am J Med , vol.99 , pp. 636-641
    • Grey, A.B.1    Stapleton, J.P.2    Evans, M.C.3    Tatnell, M.A.4    Ames, R.W.5    Reid, I.R.6
  • 13
    • 0032412151 scopus 로고    scopus 로고
    • Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer
    • A Resch E Biber M Seifert H Resch 1998 Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer Acta Oncol 37 661 664
    • (1998) Acta Oncol , vol.37 , pp. 661-664
    • Resch, A.1    Biber, E.2    Seifert, M.3    Resch, H.4
  • 18
    • 0031003458 scopus 로고    scopus 로고
    • Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: A randomized study in premenopausal breast cancer patients
    • T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa 1997 Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients J Clin Oncol 15 1341 1347
    • (1997) J Clin Oncol , vol.15 , pp. 1341-1347
    • Saarto, T.1    Blomqvist, C.2    Valimaki, M.3    Makela, P.4    Sarna, S.5    Elomaa, I.6
  • 19
    • 0031057249 scopus 로고    scopus 로고
    • Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study
    • PD Delmas R Balena E Confravreux C Hardouin P Hardy A Bremond 1997 Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study J Clin Oncol 13 955 962
    • (1997) J Clin Oncol , vol.13 , pp. 955-962
    • Delmas, P.D.1    Balena, R.2    Confravreux, E.3    Hardouin, C.4    Hardy, P.5    Bremond, A.6
  • 21
    • 0035196356 scopus 로고    scopus 로고
    • Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. the effect of adjuvant clodronate treatment
    • L Vehmanen T Saarto I Elomaa P Makela M Valimaki C Blomqvist 2001 Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment Eur J Cancer 37 2373 2378
    • (2001) Eur J Cancer , vol.37 , pp. 2373-2378
    • Vehmanen, L.1    Saarto, T.2    Elomaa, I.3    Makela, P.4    Valimaki, M.5    Blomqvist, C.6
  • 22
    • 4544349095 scopus 로고    scopus 로고
    • Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure
    • L Vehmanen T Saarto J Risteli L Risteli C Blomqvist I Elomaa 2004 Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure Breast Cancer Res Treat 87 181 188
    • (2004) Breast Cancer Res Treat , vol.87 , pp. 181-188
    • Vehmanen, L.1    Saarto, T.2    Risteli, J.3    Risteli, L.4    Blomqvist, C.5    Elomaa, I.6
  • 24
    • 0034037097 scopus 로고    scopus 로고
    • Osteoporosis due to cancer treatment: Pathogenesis and management
    • J Pfeilschifter IJ Diel 2000 Osteoporosis due to cancer treatment: pathogenesis and management J Clin Oncol 18 1570 1593
    • (2000) J Clin Oncol , vol.18 , pp. 1570-1593
    • Pfeilschifter, J.1    Diel, I.J.2
  • 29
    • 0035148170 scopus 로고    scopus 로고
    • Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a ramdomized controlled trial
    • T Saarto C Blomqvist P Virkkunen I Elomaa 2001 Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a ramdomized controlled trial J Clin Oncol 19 10 17
    • (2001) J Clin Oncol , vol.19 , pp. 10-17
    • Saarto, T.1    Blomqvist, C.2    Virkkunen, P.3    Elomaa, I.4
  • 30
    • 0030474026 scopus 로고    scopus 로고
    • Clodronate decreases the frequency of skeletal metastases in women with breast cancer
    • JA Kanis T Powles AH Paterson EV McCloskey S Ashley 1996 Clodronate decreases the frequency of skeletal metastases in women with breast cancer Bone 19 663 667
    • (1996) Bone , vol.19 , pp. 663-667
    • Kanis, J.A.1    Powles, T.2    Paterson, A.H.3    McCloskey, E.V.4    Ashley, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.